Dufour J-F, Scherer R, Balp M-M, et al. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review. Endocrine and Metabolic Science. 2021;3:1–9.

Arrese M, Feldstein AE. Nash-related cirrhosis: an occult liver disease burden. Hepatol Commun. 2017;1(2):84–6.

Article  PubMed  Google Scholar 

Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2(12):1048–58.

Article  PubMed  Google Scholar 

European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402.

Article  Google Scholar 

Singh S, Allen AM, Wang Z, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643–54. e641-649; quiz e639-640

Article  PubMed  Google Scholar 

Adams LA, Angulo P, Lindor KD. Nonalco- holic fatty liver disease. CMAJ. 2005;172(7):899–905.

Article  PubMed  Google Scholar 

Yeo SC, Ong WM, Cheng KSA, et al. Weight loss after bariatric surgery predicts an improvement in the non-alcoholic fatty liver disease (NAFLD) fibrosis score. Obes Surg. 2019;29(4):1295–300.

Article  PubMed  Google Scholar 

Ruiz-Tovar J, Zubiaga L. Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomy. Surg Obes Relat Dis. 2019;15(9):1447–53.

Article  PubMed  Google Scholar 

Cazzo E, Pareja JC, Chaim EA. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Med J. 2017;135(3):277–95.

Article  PubMed  Google Scholar 

Lassailly G, Caiazzo R, Ntandja-Wandji LC, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159(4):1290–1301 e1295.

Article  PubMed  Google Scholar 

Williams ALB, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis relationship to cirrhosis. Gastroenterology. 1988;95(3):734–9.

Article  CAS  PubMed  Google Scholar 

Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441–7.

Article  CAS  PubMed  Google Scholar 

Ruffillo G, Fassio E, Alvarez E, et al. Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54(1):160–3.

Article  PubMed  Google Scholar 

Sun W, Cui H, Li N, et al. Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study. Hepatol Res. 2016;46(9):862–70.

Article  CAS  PubMed  Google Scholar 

Roh YH, Kang BK, Jun DW, et al. Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center. Sci Rep. 2021;11(1):13616.

Article  CAS  PubMed  Google Scholar 

Rungta S, Kumari S, Deep A, et al. APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection. J Family Med Prim Care. 2021;10(11):4082–8.

Article  PubMed  Google Scholar 

Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.

Article  PubMed  Google Scholar 

Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–25.

Article  CAS  PubMed  Google Scholar 

Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104–12.

Article  CAS  PubMed  Google Scholar 

Soresi M, Cabibi D, Giglio RV, et al. The prevalence of NAFLD and fibrosis in bariatric surgery patients and the reliability of noninvasive diagnostic methods. Biomed Res Int. 2020;2020:5023157.

Article  PubMed  Google Scholar 

Algooneh A, Almazeedi S, Al-Sabah S, et al. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy. Surg Endosc. 2016;30(5):1983–7.

Article  PubMed  Google Scholar 

Li Q, Ren X, Lu C, et al. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT </= 2 ULN: a retrospective cohort study. Medicine (Baltimore). 2017;96(12):e6336.

Article  CAS  PubMed  Google Scholar 

Yunihastuti E, Wicaksana B, Wiraguna A, et al. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients. BMC Infect Dis. 2020;20(1):372.

Article  CAS  PubMed  Google Scholar 

Pimentel S, Strobel R, Gonçalves C, et al. Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery. Arq Gastroenterol. 2010;47(2):170–3.

Article  PubMed  Google Scholar 

Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45(4):600–6.

Article  PubMed  Google Scholar 

Sasaki A, Nitta H, Otsuka K, et al. Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne). 2014;5:164.

Article  PubMed  Google Scholar 

Pérez-Gutiérrez O, Hernández-Rocha C, Candia-Balboa R, et al. Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. Ann Hepatol. 2013;12:416–24.

Article  PubMed  Google Scholar 

Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108–13.

Article  CAS  PubMed  Google Scholar 

Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.

Article  PubMed  Google Scholar 

Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1):8–15.

Article  PubMed  Google Scholar 

Wallace AE, Young-Xu Y, Hartley D, et al. Racial, socioeconomic, and rural–urban disparities in obesity-related bariatric surgery. Obes Surg. 2010;20(10):1354–60.

Article  PubMed  Google Scholar 

Sheka AC, Kizy S, Wirth K, et al. Racial disparities in perioperative outcomes after bariatric surgery. Surg Obes Relat Dis. 2019;15(5):786–93.

Article  PubMed  Google Scholar 

Welsh LK, Luhrs AR, Davalos G, et al. Racial disparities in bariatric surgery complications and mortality using the MBSAQIP data registry. Obes Surg. 2020;30(8):3099–110.

Article  PubMed  Google Scholar 

De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26(8):1659–96.

Article  PubMed  Google Scholar 

Mummadi RR, Kasturi KS, Chennareddygair S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clinical Gastro and Hepatol. 2008;6:1396–402.

Article  Google Scholar 

Chavez-Tapia NC, Tellez-Avila FI, Barrientose-Gutierrez T. et al Bariatric surgery for non-alco- holic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;Issue 1:Art No: CD007340. https://doi.org/10.1002/14651858.CD007340.pub2.

Article  Google Scholar